Yüksel Ürün: ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients

Yüksel Ürün, Professor of Medical Oncology at AnkaraUniversity, shared the photo of Pashtoon Kasi on X, with the following text:

“ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients.

Promising results from BESPOKE CRC and AGITG DYNAMIC-Rectal trials.

A step forward in personalized cancer care!”

Source: Yüksel Ürün / X